Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2014
09/04/2014US20140249197 Novel indole derivatives as selective androgen receptor modulators (sarms)
09/04/2014US20140249196 N-benzylbenzimidazole modulators of pparg
09/04/2014US20140249195 7-azoniabicyclo[2.2.1]heptane derivatives, methods of production, and pharmaceutical uses thereof
09/04/2014US20140249193 Modulators of mitochondrial protein import
09/04/2014US20140249191 Compositions for Controlling Vascularization in Ophthalmological and Dermatological Diseases
09/04/2014US20140249190 Fast Dissolving Tablet
09/04/2014US20140249185 Therapeutic Agents Useful for Treating Pain
09/04/2014US20140249184 Polymer-based surgically implatable haloperidol delivery systems and methods for their production and use
09/04/2014US20140249182 Method of treating thermoregulatory dysfunction with paroxetine
09/04/2014US20140249181 Tropolone compounds for treating or preventing retroviral infection
09/04/2014US20140249180 Tau aggregation inhibitor
09/04/2014US20140249178 Compositions and methods for treating viral diseases
09/04/2014US20140249177 Salt forms of bicyclic heterocyclic derivatives
09/04/2014US20140249176 Protein synthesis required for long-term memory is induced by pkc activation on days preceding associative learning
09/04/2014US20140249173 Glutamate agents in the treatment of mental disorders
09/04/2014US20140249172 Intranasal naltrexone
09/04/2014US20140249171 Oral formulations and lipophilic salts of methylnaltrexone
09/04/2014US20140249169 1-pyrazolyl-3- (4- ((2 -anilinopyrimidin- 4 - yl) oxy) napththalen- 1- yl) ureas as p38 map kinase inhibitors
09/04/2014US20140249168 Trifluoromethyl-substituted fused pyrimidines and their use
09/04/2014US20140249167 Administration of NEDD8-Activating Enzyme Inhibitor
09/04/2014US20140249166 Methods of treating patients suffering from movement disorders
09/04/2014US20140249165 Purine derivatives for treatment of cystic diseases
09/04/2014US20140249160 Treatment of hearing and balance impairments with redox-active therapeutics
09/04/2014US20140249158 Therapeutic Nanoparticles Comprising a Therapeutic Agent and Methods of Making and Using Same
09/04/2014US20140249156 Treatment Of Blood Lipid Abnormalities And Other Conditions
09/04/2014US20140249155 Spectinamides as anti-tuberculosis agents
09/04/2014US20140249153 Fixed dose combination of bimatoprost and brimonidine
09/04/2014US20140249152 Treatment for gastroparesis using sepiapterin
09/04/2014US20140249150 Activators of pyruvate kinase m2 and methods of treating disease
09/04/2014US20140249147 Substituted Bicyclic Aza-Heterocycles and Analogues as Sirtuin Modulators
09/04/2014US20140249146 4-ALKYL SUBSTITUTED 3,4-DIHYDROPYRROLO[1,2-a]PYRAZIN-1(2H)-ONE DERIVATIVES AS KINASES INHIBITORS
09/04/2014US20140249141 1,4-diazabicyclo[3.2.2]nonanes as neuronal nicotinic acetylcholine receptor ligands
09/04/2014US20140249140 Nerve Agent Antidotes
09/04/2014US20140249138 Azaindoles useful as inhibitors of jak and other protein kinases
09/04/2014US20140249137 Pyrimidine compounds as tuberculosis inhibitors
09/04/2014US20140249136 Parenteral Formulations of Dopamine Agonists
09/04/2014US20140249135 Pim kinase inhibitors and methods of their use
09/04/2014US20140249133 Substituted benzylindazoles for use as bub1 kinase inhibitors in the treatment of hyperproliferative diseases
09/04/2014US20140249125 High enhancer-loading polyacrylate formulation for transdermal applications
09/04/2014US20140249124 Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same
09/04/2014US20140249123 Extended release biodegradable ocular implants
09/04/2014US20140249119 Estra-1,3,5(10),16-tetraene-3-carboxamide derivatives, processes for their preparation, pharmaceutical preparations comprising them and their use for preparing medicaments
09/04/2014US20140249118 Treatment of oral lichen planus with a combination of triamcinolone and retinoic acid
09/04/2014US20140249117 Active ingredient combination of a retinoid and a hormone combination with contraceptive action as medicament for treatment of skin diseases
09/04/2014US20140249116 Acne Solution
09/04/2014US20140249115 Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
09/04/2014US20140249113 Compositions for oral adminstration of zoledronic acid or related compounds for treating paget's disease of bone
09/04/2014US20140249112 Compositions for oral administration of zoledronic acid or related compounds for treating low back pain
09/04/2014US20140249111 Compositions for oral administration of zoledronic acid or related compounds for treating multiple myeloma
09/04/2014US20140249110 Treatment of arthritis using dosage forms for oral administration of zoledronic acid or related compounds
09/04/2014US20140249109 Compositions for oral administration of zoledronic acid or related compounds for treating ankylosing spondylitis
09/04/2014US20140249108 Compositions for oral administration of zoledronic acid or related compounds for treating musculoskeletal pain
09/04/2014US20140249107 Dosage forms for oral administration of zoledronic acid or related compounds for treating disease
09/04/2014US20140249103 Human milk oligosaccharides to promote growth of beneficial bacteria
09/04/2014US20140249102 Topical Applicator Composition and Process for Treatment of Radiologically Contaminated Dermal Injuries
09/04/2014US20140249101 Methods for treating hepatitis c virus infection
09/04/2014US20140249100 Compounds, compositions, and methods for preventing metastasis of cancer cells
09/04/2014US20140249099 Cancer therapy
09/04/2014US20140249098 Pharmaceutical Composition Comprising Dapagliflozin and Cyclodextrin
09/04/2014US20140249097 Inhibition of HIF-1 activation for Anti-Tumor and Anti-Inflammatory responses
09/04/2014US20140249096 Combination of compounds for treating or preventing skin diseases
09/04/2014US20140249095 Method for Inhibiting Spinocerebellar Ataxia
09/04/2014US20140249093 Carrier-Linked Prodrugs Having Reversible Carboxylic Ester Linkages
09/04/2014US20140249085 Calcitonin products and therapies for treating inflammatory or degenerative diseases
09/04/2014US20140249074 Antiviral compounds
09/04/2014US20140249031 Micelle-coated crystalline particles
09/04/2014US20140248609 Gene detection assay for improving the likelihood of an effective response to an egfr antagonist cancer therapy
09/04/2014US20140248383 Sleep quality improving agent
09/04/2014US20140248382 Curcuminoid-based compound/stevioside-containing complex for the prevention and treatment of an influenza virus infection
09/04/2014US20140248381 Composition for inhibiting vascular aging comprising syringaresinol
09/04/2014US20140248379 Process for producing an extract containing tetrahydrocannabinol and cannabidiol from cannabis plant material, and cannabis extracts
09/04/2014US20140248378 Pyrimidinone compounds and their use
09/04/2014US20140248377 Multiple emulsion
09/04/2014US20140248376 Compositions for treatment of skin and ear infections
09/04/2014US20140248375 Combination Therapy for Treating Proliferative Diseases
09/04/2014US20140248374 Compositions and multi-step methods of using the same for the treatment of jellyfish stings
09/04/2014US20140248372 Bone morphogenetic protein pathway activation, compositions for ossification, and methods related thereto
09/04/2014US20140248370 Enhancement Composition
09/04/2014US20140248369 Eye health composition and method using plant derived seed extract rich in essential fatty acids derived from perilla seed and carotenoids
09/04/2014US20140248367 Spray-dried pharmaceutical compositions comprising active agent nanoparticles
09/04/2014US20140248364 Divalent-metal coated nanoparticles for delivery of compositions into the central nervous system by nasal insufflation
09/04/2014US20140248363 Nanoparticulate phosphate adsorbent on the basis of maghemite or maghemite/magnetite, production and uses thereof
09/04/2014US20140248362 Sustained-release preparation
09/04/2014US20140248359 Novel formulation of diclofenac
09/04/2014US20140248358 Therapeutic Nanoparticles Comprising a Therapeutic Agent and Methods of Making and Using Same
09/04/2014US20140248357 Respiratory Disease Treatment
09/04/2014US20140248353 Dosage form for insertion into the mouth
09/04/2014US20140248352 Chewable enteric coated aspirin tablets
09/04/2014US20140248351 Pharmaceutical composition comprising fesoterodine
09/04/2014US20140248349 Process for the preparation of a solid, orally administrable pharmaceutical composition
09/04/2014US20140248347 Pharmaceutical compositions of n-methyl-2-[3-((e)-2-pyridin-2-yl-vinyl)-1h-indazol-6-ylsulfanyl]-benzamide
09/04/2014US20140248346 Misuse preventative, controlled release formulation
09/04/2014US20140248345 Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with atorvastatin
09/04/2014US20140248344 Abuse resistant forms of extended release morphine, method of use and method of making
09/04/2014US20140248343 Abuse resistant forms of extended release morphine, method of use and method of making
09/04/2014US20140248342 Fe(III) 2,4-Dioxo-1-Carbonyl Complexes For Treatment And Prophylaxis Of Iron Deficiency Symptoms And Iron Deficiency Anaemias
09/04/2014US20140248341 Alcohol resistant enteric pharmaceutical compositions
09/04/2014US20140248340 Coated controlled release active agent carriers
09/04/2014US20140248338 Compositions and methods for silencing aldehyde dehydrogenase
09/04/2014US20140248335 Compositions of multicationic drugs for reducing interactions with polyanionic biomolecules and methods of use thereof
1 ... 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 ... 7860